Calcium Administration in Life-saving Management During Massive Hemorrhage

Launched by LONDON HEALTH SCIENCES CENTRE RESEARCH INSTITUTE OR LAWSON RESEARCH INSTITUTE OF ST. JOSEPH'S · Feb 5, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how calcium treatment might help patients who are experiencing massive bleeding due to trauma. The researchers want to see if giving calcium can improve the care of these patients when they receive blood transfusions. In this study, patients at Victoria Hospital in London, Ontario, who are part of the Massive Hemorrhage Protocol (a set of steps to manage severe bleeding) will be randomly chosen to receive either calcium gluconate (a type of calcium supplement) or a placebo (a harmless substance with no active ingredients) every time they get four units of red blood cells.

To participate in this trial, you must be an adult trauma patient receiving treatment for severe bleeding at the hospital. Unfortunately, individuals under 18 years old or those who are pregnant cannot take part. While the study is not yet recruiting participants, those who join will contribute to important research that could help improve treatment for future trauma patients experiencing massive hemorrhage.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult trauma patients undergoing the MHP at Victoria Hospital, London, Ontario
• Exclusion Criteria:
• • Under the age of 18
• • Pregnant